Cell And Gene Therapies Test New Waters In Pricing And Reimbursement

As new cell and gene therapies come to market, the questions of how to pay for these expensive one-time treatments and how to ensure patient access to them were at the forefront at the annual Alliance for Regenerative Medicines Cell and Gene meeting on the Mesa, held October 3 and 4 in San Diego, California. Explore topics covered during the meeting, including how to get payers to realize the value of the treatments over the long term, and other ideas for covering the cost of these therapies in this illuminating article from Scrip.